-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Tamoxifen and raloxifene are selective ER modulators that inhibit ERs in breast tissue and reduce risk
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/WN7F3WW6RQFDkHay87a3Dx
November 18, 2020 - Lung cancer is a proliferation of malignant cells that originate in lung
tissue.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-supplemental-screening-in-women-with-dense-/breast-cancer-screening-january-2016
January 11, 2016 - in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-promotion-behavioral-counseling-1996
January 01, 1996 - Calcif Tissue Int . 1990;47:194–201. [ PubMed ] 135A. Chapuy MC, Arlot ME, Delmas PD, et al.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Tamoxifen and raloxifene are selective ER modulators that inhibit ERs in breast tissue and reduce risk
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
August 19, 2024 - the lactating person’s
diet30 and dietary supplement use,31 by the fatty acid composition of adipose tissue
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
November 18, 2024 - the lactating person’s diet30 and dietary supplement use,31
by the fatty acid composition of adipose tissue
-
hcup-us.ahrq.gov/reports/methods/2008_05.pdf
January 01, 2008 - patients admitted
from long-term-care facilities, patients with diseases of the skin, subcutaneous tissue
-
effectivehealthcare.ahrq.gov/health-topics/cancer
-
effectivehealthcare.ahrq.gov/health-topics/genetic-disorders
-
effectivehealthcare.ahrq.gov/health-topics/retinal-detachment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - appropriate
time interval after exposure)
Lack of alternative causes
Drug levels in body fluids or tissues
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-206-fullreport.pdf
November 01, 2019 - radiation dose for pediatric patients is highly problematic
because the developing cellular structures and tissues
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - appropriate
time interval after exposure)
Lack of alternative causes
Drug levels in body fluids or tissues
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - include primary brain tumors, and those derived from the peripheral nervous system
(neuroblastoma), soft tissues
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
June 01, 2012 - In the example of early stage breast cancer, the gold standard could be the tissue that is removed during
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - validity and reporting adequacy: Are negative control materials used in the
study from the same type of tissue
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-fullreport.pdf
August 01, 2017 - The probe transmits two wavelengths of
light through the vascular tissue and measures the differential
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
June 01, 2012 - In the example of early stage breast cancer, the gold standard could be the tissue that is removed during
-
effectivehealthcare.ahrq.gov/health-topics/prostate-cancer